ABIVAX earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €-4.83 | €-4.83 | 2026-06-19T16:35:43Z |
| 2024 | 2024-12-31 | €-2.80 | €-2.80 | 2026-06-19T16:35:43Z |
| 2023 | 2023-12-31 | €-3.43 | €-3.43 | 2026-06-19T16:35:43Z |
Revenue & profit (EUR)
| Concept | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Profit for the year | -€336.1M | -€176.2M | -€147.7M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in ABIVAX's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.